Abstract |
ES-2 ( IVRRADRAAVP), an endostatin-derived synthetic polypeptide, contains the amino acids 50-60 of endostatin from its N terminus, and it had no inhibitory effects on tumor growth in vivo. In order to increase the targeted delivery of ES-2 to tumors and further enhance the activity, the polypeptide RGD-4C (ACDCRGDCFC) was introduced into ES-2, and the effects of RGD-4C position and RGD-4C disulfide bonds on polypeptides activity were investigated. When RGD-4C polypeptides (with or without disulfide bonds) were introduced to the N-terminals of synthesized ES-2, the modified ES-2 showed significant antitumor activity in vivo. Cell proliferation and chicken chorioallantoic membrane (CAM) assay results showed that disulfide bonds had no significant effects on RGD-4C-modified ES-2 antiangiogenic activity. Furthermore, the target of modified peptides was integrin alpha5beta1, rather than integrin alphavbeta3 as previous studies mentioned.
|
Authors | Runting Yin, Heng Zheng, Tao Xi, Han-Mei Xu |
Journal | Bioconjugate chemistry
(Bioconjug Chem)
Vol. 21
Issue 7
Pg. 1142-7
(Jul 21 2010)
ISSN: 1520-4812 [Electronic] United States |
PMID | 20515045
(Publication Type: Journal Article)
|
Chemical References |
- AP25 peptide
- Angiogenesis Inhibitors
- Antineoplastic Agents
- Disulfides
- Endostatins
- Integrin alpha5beta1
- Peptide Fragments
- Peptides
|
Topics |
- Angiogenesis Inhibitors
(chemical synthesis, chemistry, pharmacology)
- Animals
- Antineoplastic Agents
(chemical synthesis, chemistry, pharmacology)
- Binding, Competitive
- Cattle
- Cell Line
- Cell Proliferation
(drug effects)
- Chickens
- Chorioallantoic Membrane
(drug effects)
- Disulfides
(metabolism)
- Drug Screening Assays, Antitumor
- Endostatins
(chemical synthesis, chemistry, pharmacology)
- Endothelial Cells
(drug effects)
- Female
- Humans
- Integrin alpha5beta1
(chemistry)
- Mice
- Mice, Inbred C57BL
- Peptide Fragments
(chemical synthesis, chemistry, pharmacology)
- Peptides
(chemical synthesis, chemistry, pharmacology)
|